OQS
MIST icon

Occudo Quantitative Strategies’s Milestone Pharmaceuticals MIST Stock Holding History

Occudo Quantitative Strategies’s Portfolio MIST Stock Details MIST Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q2 		– Sell
-10,460
Closed -$41.2K – 1175
2023
Q1 		$41.2K Sell
10,460
-28,668
-73% -$105K ﹤0.01% 853
2022
Q4 		$155K Buy
+39,128
New +$206K 0.02% 811

Other funds holding MIST

RI
RTW Investments New York $10B AUM 135.35% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return
VA
VR Adviser New York $2.68B AUM 422.73% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
BL
Bleichroeder LP New York $579M AUM 94.36% 1-Year Est. Return
AFA
Alta Fundamental Advisers New York $265M AUM 98.61% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Barclays
Barclays London, United Kingdom $416B AUM 33.63% 1-Year Est. Return
BC
Boxer Capital San Diego, California $2.04B AUM 108.39% 1-Year Est. Return

Occudo Quantitative Strategies's MIST Position: Q2 2023 in Review

Occudo Quantitative Strategies sold out of Milestone Pharmaceuticals (MIST) in Q2 2023, closing a stake of 10,460 shares — an estimated $41.2K sold.

Occudo Quantitative Strategies first reported a position in MIST in Q4 2022 and held it in 2 quarters. The position peaked at $155K in Q4 2022. 48 funds tracked by Wall St. Rank hold MIST as of Q2 2023.

  • Occudo Quantitative Strategies reported no remaining Milestone Pharmaceuticals position as of Q2 2023 after selling out during the quarter.
  • Occudo Quantitative Strategies sold 10,460 Milestone Pharmaceuticals shares in Q2 2023, an estimated $41.2K.
  • Occudo Quantitative Strategies first reported a position in Milestone Pharmaceuticals in Q4 2022 and held it in 2 quarters.
  • Occudo Quantitative Strategies's Milestone Pharmaceuticals position peaked at $155K in Q4 2022.
  • 48 funds tracked by Wall St. Rank held Milestone Pharmaceuticals as of Q2 2023.

Based on Occudo Quantitative Strategies's 13F filing for Q2 2023, filed 14 Aug 2023.